Results 291 to 300 of about 101,449 (340)
Some of the next articles are maybe not open access.
Journal of clinical pharmacology, 2018
Pharmacokinetics and antithrombotic effects of the Factor Xa inhibitor rivaroxaban were studied in subjects with mild renal insufficiency concurrently taking the P‐glycoprotein and moderate CYP3A inhibitor verapamil, a drug commonly administered to ...
D. Greenblatt +5 more
semanticscholar +1 more source
Pharmacokinetics and antithrombotic effects of the Factor Xa inhibitor rivaroxaban were studied in subjects with mild renal insufficiency concurrently taking the P‐glycoprotein and moderate CYP3A inhibitor verapamil, a drug commonly administered to ...
D. Greenblatt +5 more
semanticscholar +1 more source
Clinical Pharmacokinetics of Verapamil
Clinical Pharmacokinetics, 1984Verapamil is widely used in the treatment of supraventricular tachyarrhythmias as well as for hypertension and control of symptoms in angina pectoris. Unlike other calcium antagonists, detailed pharmacokinetic data are available for verapamil. Plasma concentrations of verapamil appear to correlate with both electrophysiological and haemodynamic ...
Scott R. Hamann +5 more
openaire +3 more sources
Verapamil and Pulmonary Hypertension
Acta Medica Scandinavica, 1978ABSTRACT.We report on the effect of verapamil in 12 patients suffering from pulmonary hypertension. The drug caused a slight, but statistically significant decrease in mean pulmonary artery pressure and in the work performance by the right ventricle. The mean pressure of the right atrium, the end‐diastolic pressure of the right ventricle, the pulmonary
Knud Landmark +3 more
openaire +3 more sources
Archives of Internal Medicine, 1986
To the Editor. —The use of verapamil hydrochloride was shown to be effective for either prevention 1 or treatment of episodes of supraventricular tachycardia. 2 Recently, we observed an unusual phenomenon of tachyphylaxis using this agent. Report of a Case.
Dan Aderka, Jack Pinkhas, Ariel Levy
openaire +2 more sources
To the Editor. —The use of verapamil hydrochloride was shown to be effective for either prevention 1 or treatment of episodes of supraventricular tachycardia. 2 Recently, we observed an unusual phenomenon of tachyphylaxis using this agent. Report of a Case.
Dan Aderka, Jack Pinkhas, Ariel Levy
openaire +2 more sources
Annals of Internal Medicine, 1982
Excerpt To the editor: Verapmil has been recently approved by the FDA for the treatment of supraventricular tachycardia.
John A. Marx +3 more
openaire +2 more sources
Excerpt To the editor: Verapmil has been recently approved by the FDA for the treatment of supraventricular tachycardia.
John A. Marx +3 more
openaire +2 more sources
Postinfarct Treatment with Verapamil
Drugs, 1993In the Danish Verapamil Infarction Trial II (DAVIT II), treatment with verapamil 360 mg/day improved reinfarction-free survival compared with administration of placebo. Verapamil appears to effectively prevent reinfarction and sudden death, i.e. sudden events (hazard ratio 0.78 compared with placebo, 95% confidence limits 0.62 to 0.99).
openaire +3 more sources
Verapamil for ventricular tachycardia
The American Journal of Emergency Medicine, 2007Fascicular ventricular tachycardia (VT; also known as left VT) belongs to a subclass of idiopathic VTs. It can be confused with VT and supraventricular tachycardia. It is an entity well recognized by the cardiology community but not as frequently by emergency medicine physicians because of its infrequency. Idiopathic left VT was first described in 1979.
Huck Chin Chew, Swee Han Lim
openaire +3 more sources
Antimanic effects of verapamil
American Journal of Psychiatry, 1984When the authors compared the antimanic effects of verapamil, lithium carbonate, and placebo, no differences were seen between lithium and verapamil and both were more effective than placebo in reducing symptoms. No major side effects emerged during the study.
Price Wa +4 more
openaire +2 more sources
The Canadian Journal of Psychiatry, 1986
The authors report two cases of Bipolar Affective Disorder which were responsive to Lithium therapy in the past, but could no longer be treated with Lithium due to hyperparathyroidism in the first case and noncompliance in the second. In both cases, successful control of hypomania was achieved with Verapamil, but treatment of depression required the ...
Peter C. Williamson, Leigh Solomon
openaire +3 more sources
The authors report two cases of Bipolar Affective Disorder which were responsive to Lithium therapy in the past, but could no longer be treated with Lithium due to hyperparathyroidism in the first case and noncompliance in the second. In both cases, successful control of hypomania was achieved with Verapamil, but treatment of depression required the ...
Peter C. Williamson, Leigh Solomon
openaire +3 more sources